Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.

scientific article published on 10 December 2009

Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1468-3083.2009.03537.X
P698PubMed publication ID20015170

P2093author name stringJ Schmitt
D E Ford
P433issue8
P921main subjectcirculatory systemQ11068
P304page(s)885-892
P577publication date2009-12-10
P1433published inJournal of the European Academy of Dermatology and VenereologyQ15760872
P1476titlePsoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.
P478volume24

Reverse relations

cites work (P2860)
Q89970104A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates
Q48063769Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption
Q54967829Association between psoriasis and asthma risk: A meta-analysis.
Q34381490Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies
Q57403239Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis
Q55135968Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients.
Q47218445Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
Q51009674Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
Q38076496Cardiovascular aspects of psoriasis: an updated review
Q34812877Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review
Q40031011Cardiovascular risk factors in subjects with psoriasis: a cross-sectional general population study
Q33823950Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.
Q90261441Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark
Q34140480Comorbidities and cardiovascular risk factors in patients with psoriasis
Q46625469Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study
Q39417482Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
Q64903242Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.
Q37268868Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis
Q45983342Epidemiology of mental health comorbidity in psoriasis.
Q38098647Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.
Q34497024Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study
Q31098137Increased overall drug utilization in patients with psoriasis: a case-control study based on Dutch general practitioner data
Q37954016Management of psoriasis and its comorbidities in primary care
Q37420435Primary care-based screening for cardiovascular risk factors in patients with psoriasis.
Q44942262Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study
Q36824796Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies
Q37449514Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study
Q46838241Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
Q34643790Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis
Q43693973Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study
Q37969835Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments
Q38114903Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis
Q37475408Psychosomatic paradigms in psoriasis: Psoriasis, stress and mental health
Q36741063Rapid improvement of palmoplantar psoriasis after cessation of smoking.
Q36515160Risk and predictors of cardiovascular disease in psoriasis: a population-based study
Q38983615Risk of depression in women with psoriasis: a cohort study
Q46048754Risk of myocardial infarction in psoriasis patients: a retrospective cohort study.
Q38056160The association between psoriasis and dyslipidaemia: a systematic review
Q38064779The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies
Q38702268The association between the clinical diversity of psoriasis and depressive symptoms: the HUNT Study, Norway
Q39358289The experience of having psoriasis through the lens of the International Classification of Functioning, Disability and Health (ICF).
Q26862537The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis
Q84441860[Current topics in psoriasis]
Q87140366[Genome-associated studies in chronic inflammatory dermatoses]

Search more.